Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001139369) titled 'Weight loss medications on exercise capacity in Pulmonary Arterial Hypertension (PAH) patients' on Sept. 14.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Primary Sponsor: Sydney Local Health District
Condition:
Pulmonary arterial hypertension
Obese
Overweight
Pulmonary arterial hypertension
Obese
Overweight
Metabolic and Endocrine - Other metabolic disorders
Respiratory - Other respiratory disorders / diseases
Diet and Nutrition - Obesity
Intervention:
Medication: Semaglutide
Dose: 2.4mg weekly f...